Enrollment And Outcomes 91 Aml Patients Were Treated With Decitabine

Enrollment and outcomes. 91 AML patients were treated with decitabine ...
Enrollment and outcomes. 91 AML patients were treated with decitabine ...
Enrollment and outcomes. 91 AML patients were treated with decitabine ...
Enrollment and outcomes. 91 AML patients were treated with decitabine ...
Enrollment and outcomes in patients with decitabine treatment ...
Enrollment and outcomes in patients with decitabine treatment ...
Enrollment and outcomes in patients with decitabine treatment ...
Enrollment and outcomes in patients with decitabine treatment ...
Changes in primary blasts of AML patients treated with decitabine and ...
Changes in primary blasts of AML patients treated with decitabine and ...
Outcomes of patients treated with decitabine plus dasatinib. A, Overall ...
Outcomes of patients treated with decitabine plus dasatinib. A, Overall ...
Prognostic impact of MLL5 expression in AML patients treated with ...
Prognostic impact of MLL5 expression in AML patients treated with ...
-Overview of retrospective studies of decitabine in patients with AML ...
-Overview of retrospective studies of decitabine in patients with AML ...
Recurrent transcriptional responses in AML and MDS patients treated ...
Recurrent transcriptional responses in AML and MDS patients treated ...
Efficacy and safety of decitabine in treatment of elderly patients with ...
Efficacy and safety of decitabine in treatment of elderly patients with ...
-Overview of retrospective studies of decitabine in patients with AML ...
-Overview of retrospective studies of decitabine in patients with AML ...
OS in patients treated with at least 4 cycles of decitabine vs. total ...
OS in patients treated with at least 4 cycles of decitabine vs. total ...
Recurrent transcriptional responses in AML and MDS patients treated ...
Recurrent transcriptional responses in AML and MDS patients treated ...
Recurrent transcriptional responses in AML and MDS patients treated ...
Recurrent transcriptional responses in AML and MDS patients treated ...
Recurrent transcriptional responses in AML and MDS patients treated ...
Recurrent transcriptional responses in AML and MDS patients treated ...
Decitabine in older patients with AML: quality of life results of the ...
Decitabine in older patients with AML: quality of life results of the ...
A phase 2 study of decitabine with or without carboplatin and arsenic ...
A phase 2 study of decitabine with or without carboplatin and arsenic ...
Pretransplantation MRD in Older Patients With AML After Treatment With ...
Pretransplantation MRD in Older Patients With AML After Treatment With ...
Table 1 from Comparison Between Decitabine and Azacitidine for Patients ...
Table 1 from Comparison Between Decitabine and Azacitidine for Patients ...
(PDF) Successful treatment of patients with acute myeloid leukemia and ...
(PDF) Successful treatment of patients with acute myeloid leukemia and ...
Odds ratio of decitabine response in AML patients according to age ...
Odds ratio of decitabine response in AML patients according to age ...
(a) Overall survival among patients treated with azacitidine vs ...
(a) Overall survival among patients treated with azacitidine vs ...
Decitabine in patients with myelodysplastic syndromes: A multi‐center ...
Decitabine in patients with myelodysplastic syndromes: A multi‐center ...
Decitabine in older patients with AML: quality of life results of the ...
Decitabine in older patients with AML: quality of life results of the ...
(PDF) Sequential Treatment with Cytarabine and Decitabine Has an ...
(PDF) Sequential Treatment with Cytarabine and Decitabine Has an ...
Pretransplantation MRD in Older Patients With AML After Treatment With ...
Pretransplantation MRD in Older Patients With AML After Treatment With ...
(PDF) Decitabine Compared With Conventional Regimens in Older Patients ...
(PDF) Decitabine Compared With Conventional Regimens in Older Patients ...
Outcomes of treated secondary AML by treatment approach. (A) overall ...
Outcomes of treated secondary AML by treatment approach. (A) overall ...
T/myeloid mixed-phenotype acute leukemia treated with venetoclax and ...
T/myeloid mixed-phenotype acute leukemia treated with venetoclax and ...
Emerging Therapies for Older Adults with AML Sergio
Emerging Therapies for Older Adults with AML Sergio
Decitabine incorporation and DNA demethylation in clinical study. (A ...
Decitabine incorporation and DNA demethylation in clinical study. (A ...
Ten‐day decitabine with venetoclax versus intensive chemotherapy in ...
Ten‐day decitabine with venetoclax versus intensive chemotherapy in ...
Decitabine shows comparable OS to standard induction chemotherapy and ...
Decitabine shows comparable OS to standard induction chemotherapy and ...
Decitabine shows comparable OS to standard induction chemotherapy and ...
Decitabine shows comparable OS to standard induction chemotherapy and ...
Venetoclax with decitabine or azacitidine in the first‐line treatment ...
Venetoclax with decitabine or azacitidine in the first‐line treatment ...
PPT - AML and MDS: Highlights from 2012 PowerPoint Presentation, free ...
PPT - AML and MDS: Highlights from 2012 PowerPoint Presentation, free ...

Loading image details...

Source
Dimensions